Form D · Biotechnology
DELCATH SYSTEMS, INC.
Queensbury, NY · CIK 0000872912
Offering snapshot reported Mar 26, 2024 · SEC filing
- Reported sold
- $7M Offering amount: $7M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 19, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 26, 2024 | Initial | $7,001,113 | No comparison | 17 | SEC filing |
| Mar 31, 2023 | Initial | $24,999,999 | No comparison | 17 | SEC filing |
| Dec 16, 2022 | Initial | $3,807,499 | No comparison | 7 | SEC filing |
| Jul 22, 2022 | Initial | $4,999,999 | No comparison | 6 | SEC filing |
| Aug 27, 2019 | Initial | $9,510,434 | No comparison | 33 | SEC filing |
| Jul 25, 2019 | Initial | $20,000,000 | No comparison | 31 | SEC filing |
| Aug 3, 2018 | Initial | $1,600,000 | No comparison | 1 | SEC filing |
| Dec 14, 2004 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-508697
Source: Form D, filed Mar 26, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gilad Aharon | Director |
| Elizabeth Czerepak | Director |
| Anthony Dias | Executive |
| David J. Hoffman | Executive |
| Johnny John | Executive |
| Barbra C Keck | Executive |
| Gerard Michel | Director, Executive |
| Kevin Muir | Executive |
| Sandra Pennell | Executive |
| John Purpura | Executive |
| Martha Rook | Executive |
| William D Rueckert | Director |
| Steven Salamon | Director |
| Jennifer K Simpson | Director, Executive |
| Roger G. Stoll | Director |
| John R. Sylvester | Director |
| Marco Taglietti | Director |
| Vojo Vukovic | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
566 Queensbury Avenue
Queensbury, NY, 12804
Queensbury, NY, 12804